Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,584.00    -31.00 (-1.92%)
Bid:
1,592.00
Ask:
1,594.00
Spread: 2.00 (0.126%)
Market Cap: £3.33b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Hikma Pharmaceuticals News

LONDON BROKER RATINGS: Morgan Stanley cuts Anglo American
11 Jun 2024

LONDON BROKER RATINGS: Morgan Stanley cuts Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

Citi hikes Hikma price target, cites 'healthy trends' for injectables and US Generics
11 Jun 2024

Citi hikes Hikma price target, cites 'healthy trends' for injectables and US Generics

(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "hea...

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec
3 May 2024

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

London close: Stocks finish mixed as US GDP growth slows
25 Apr 2024

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

Hikma Pharmaceuticals backs outlook after making strong start to 2024
25 Apr 2024

Hikma Pharmaceuticals backs outlook after making strong start to 2024

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segments.

Hikma delivers strong Q1, holds on to guidance
25 Apr 2024

Hikma delivers strong Q1, holds on to guidance

(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing ...